Pulse Biosciences Inc EBITDA
Qual é o EBITDA de Pulse Biosciences Inc?
O EBITDA de Pulse Biosciences Inc é -$38.55
Qual é a definição de EBITDA?
O EBITDA é o lucro de uma empresa antes de juros, impostos, depreciação e amortização e é uma medida contábil calculada com base no lucro líquido de uma empresa, subtraído antes das despesas de juros, impostos, depreciação e amortização, como imagem da lucratividade operacional corrente de uma empresa.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA de empresas na Setor Health Care em NASDAQ em comparação com Pulse Biosciences Inc
O que Pulse Biosciences Inc faz?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Empresas com ebitda semelhantes a Pulse Biosciences Inc
- U&I Plc tem EBITDA de -£38.66
- Fujian Blue Hat Interactive Entertainment Technology tem EBITDA de -$38.66
- Inseego tem EBITDA de -$38.61
- Risecomm tem EBITDA de -¥38.58
- Boill Healthcare tem EBITDA de -HKD$38.55
- Scorpio Bulkers Inc tem EBITDA de -$38.55
- Pulse Biosciences Inc tem EBITDA de -$38.55
- 51 Credit Card tem EBITDA de -¥38.46
- Uxin Ltd tem EBITDA de -¥38.45
- Sonendo tem EBITDA de -$38.44
- Cerus tem EBITDA de -$38.42
- China Brilliant Global tem EBITDA de -HKD$38.41
- Danimer Scientific tem EBITDA de -$38.37